(Q57791799)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

R J Hené

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

D W Erkelens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

J A Joles

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

H A Koomans

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

language of work or name

English

0 references

publication date

1 December 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

8624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

1335-1338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

The hyperlipidemia of the nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity

7 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Status of the coronary arteries in the nephrotic syndrome. Analysis of 20 necropsy patients aged 15 to 35 years to determine if coronary atherosclerosis is accelerated

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

The Nephrotic Syndrome and Ischaemic Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Treatment of the hyperlipidemia of the nephrotic syndrome: a controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Effect of probucol on hyperlipidemia in patients with nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

An improved semi-automated method for the colorimetric determination of triglycerides in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Light-Scattering Immunoassay of Specific Proteins: A Review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

High density lipoproteins and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Studies on the turnover of triglyceride and esterified cholesterol in subjects with the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Catabolism of very low density lipoproteins in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990870-7

7 January 2021

10.1016/S0140-6736(88)90870-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2904053%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference